Live search
TopFind is fetching the latest matches for your search.
We reviewed 12 live results for skyrizi risankizumab rzaa and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Immunology and Biologics.
Source: AbbVie Pharmaceuticals (Thailand) Ltd.
Description
Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading.
Best for
Plaque psoriasis patients, Psoriatic arthritis management, Crohn's disease treatment and Long Term biologic therapy
Rating
Source: AbbVie Inc.
Description
Skyrizi is an FDA-approved prescription biologic medication and interleukin-23 (IL-23) inhibitor. It is used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease or ulcerative colitis. The medication is available in several forms, including a 150 mg/mL single-dose prefilled pen or syringe for subcutaneous injection, as well as an intravenous (IV) infusion for induction and an on-body injector for maintenance dosing. As a targeted immunology therapy, it helps reduce inflammation by blocking specific proteins in the body.
Best for
Moderate To Severe plaque psoriasis, Active psoriatic arthritis, Crohn's disease management, Ulcerative colitis treatment and Biologic therapy seekers
Rating
Source: AbbVie Singapore
Description
Prescription biologic for the treatment of plaque psoriasis and psoriatic arthritis. The Singapore hub serves as a key regional reference for medical documentation and treatment guidelines for risankizumab therapies in Southeast Asia.
Best for
Regional medical reference, Singapore Based patients and Biologic therapy information
Rating
| Compare | Skyrizi (risankizumab) | Skyrizi (risankizumab-rzaa) | Skyrizi (risankizumab) 150mg |
|---|---|---|---|
| Source | AbbVie Pharmaceuticals (Thailand) Ltd. | AbbVie Inc. | AbbVie Singapore |
| Description | Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading. | Skyrizi is an FDA-approved prescription biologic medication and interleukin-23 (IL-23) inhibitor. It is used to treat adults with moderate-to-severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease or ulcerative colitis. The medication is available in several forms, including a 150 mg/mL single-dose prefilled pen or syringe for subcutaneous injection, as well as an intravenous (IV) infusion for induction and an on-body injector for maintenance dosing. As a targeted immunology therapy, it helps reduce inflammation by blocking specific proteins in the body. | Prescription biologic for the treatment of plaque psoriasis and psoriatic arthritis. The Singapore hub serves as a key regional reference for medical documentation and treatment guidelines for risankizumab therapies in Southeast Asia. |
| Best for | Plaque psoriasis patients, Psoriatic arthritis management, Crohn's disease treatment and Long Term biologic therapy | Moderate To Severe plaque psoriasis, Active psoriatic arthritis, Crohn's disease management, Ulcerative colitis treatment and Biologic therapy seekers | Regional medical reference, Singapore Based patients and Biologic therapy information |
| Action | |||
| Rating |
If you want the most balanced option to start with, I recommend:
"Skyrizi (risankizumab) from AbbVie Pharmaceuticals (Thailand) Ltd.."
I picked this because This is the official medication provided by the authorized manufacturer representative in Thailand, ensuring authentic pharmaceutical supply and regulatory oversight.